drugset / Trial / NCT07146997

Evaluating the Combined Effect of Oral Premedications on Inferior Alveolar Nerve Block Effectiveness

NCT07146997

RandomizedParallel-groupQuadruple-blindSupportive care

Summary

This clinical study investigates whether the combination of ibuprofen and serratiopeptidase as oral premedication can enhance the effectiveness of the inferior alveolar nerve block (IANB) in patients with symptomatic irreversible pulpitis in mandibular teeth. Due to the inflammatory nature of the condition, standard IANB often fails, possibly due to prostaglandin-induced nerve sensitization. A total of 96 patients meeting specific inclusion criteria will be divided into four groups: Placebo Ibuprofen alone Serratiopeptidase alone Combination of ibuprofen and serratiopeptidase Pain levels will be measured using the Verbal Numerical Scale (VNS) at various treatment stages. The success of anesthesia will be determined by the absence or presence of pain during access cavity preparation and initial root canal instrumentation. Statistical analysis will compare the effectiveness between groups, with the goal of determining whether combined premedication significantly improves IANB success. The study is conducted at the Department of Operative Dentistry \& Endodontics, HITEC-IMS Taxila, over a period of six months.

Timeline

Start
2023-11-23
Primary completion
2024-11-23
Completion
2024-11-23

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ibuprofen Small molecule 400 mg Oral
Comparator Ibuprofen Small molecule 600 mg Oral
Comparator serrapeptase Protein / enzyme biologic 10 mg Oral

Indications